Details
Stereochemistry | RACEMIC |
Molecular Formula | C19H20N2O |
Molecular Weight | 292.3749 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(CN1C=CN=C1)C2=CC=C(CCC3=CC=CC=C3)C=C2
InChI
InChIKey=IAWIJHCUEPVIOO-UHFFFAOYSA-N
InChI=1S/C19H20N2O/c22-19(14-21-13-12-20-15-21)18-10-8-17(9-11-18)7-6-16-4-2-1-3-5-16/h1-5,8-13,15,19,22H,6-7,14H2
Denzimol is a new imidazole derivative with anticonvulsant properties. Denzimol suppressed electrically and chemically induced tonic seizures but did not prevent the clonic ones. Denzimol prolongs pentobarbitone sleeping times indicating that drug binds to rat liver microsomes and are potent inhibitors in the rat of mixed function monooxygense activities both in‐vitro and in‐vivo. The antiepileptic activity of the denzimol has been evaluated in patients with poorly controlled partial epilepsy by adding on the drug to the current therapy. Although denzimol increased blood concentrations of carbamazepine, correlation analysis indicated that the improvement was more likely due to intrinsic properties of denzimol. No severe side effects were reported, although several patients experienced nausea and vomiting, which caused 2 patients to drop out. The drug did not show any mutagenic activity when compared with mutagenic standards.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C264
Created by
admin on Sat Dec 16 16:04:33 GMT 2023 , Edited by admin on Sat Dec 16 16:04:33 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB06980MIG
Created by
admin on Sat Dec 16 16:04:33 GMT 2023 , Edited by admin on Sat Dec 16 16:04:33 GMT 2023
|
PRIMARY | |||
|
C78001
Created by
admin on Sat Dec 16 16:04:33 GMT 2023 , Edited by admin on Sat Dec 16 16:04:33 GMT 2023
|
PRIMARY | |||
|
73931-96-1
Created by
admin on Sat Dec 16 16:04:33 GMT 2023 , Edited by admin on Sat Dec 16 16:04:33 GMT 2023
|
PRIMARY | |||
|
100000083162
Created by
admin on Sat Dec 16 16:04:33 GMT 2023 , Edited by admin on Sat Dec 16 16:04:33 GMT 2023
|
PRIMARY | |||
|
277-642-5
Created by
admin on Sat Dec 16 16:04:33 GMT 2023 , Edited by admin on Sat Dec 16 16:04:33 GMT 2023
|
PRIMARY | |||
|
9C78O7JATH
Created by
admin on Sat Dec 16 16:04:33 GMT 2023 , Edited by admin on Sat Dec 16 16:04:33 GMT 2023
|
PRIMARY | |||
|
CHEMBL41849
Created by
admin on Sat Dec 16 16:04:33 GMT 2023 , Edited by admin on Sat Dec 16 16:04:33 GMT 2023
|
PRIMARY | |||
|
53626
Created by
admin on Sat Dec 16 16:04:33 GMT 2023 , Edited by admin on Sat Dec 16 16:04:33 GMT 2023
|
PRIMARY | |||
|
DTXSID70868275
Created by
admin on Sat Dec 16 16:04:33 GMT 2023 , Edited by admin on Sat Dec 16 16:04:33 GMT 2023
|
PRIMARY | |||
|
5241
Created by
admin on Sat Dec 16 16:04:33 GMT 2023 , Edited by admin on Sat Dec 16 16:04:33 GMT 2023
|
PRIMARY | |||
|
C031307
Created by
admin on Sat Dec 16 16:04:33 GMT 2023 , Edited by admin on Sat Dec 16 16:04:33 GMT 2023
|
PRIMARY |
ACTIVE MOIETY